Breast Cancer

The information below is intended for use by health care providers only. Please consult with your health care provider for more information about clinical trials.

S1703 OS of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) Vs Usual Care in Metastatic Hormone Receptor Positive Breast Cancer

Study Details

  • Study Site/Tumor Location: Breast
  • Study Location: All Premier
  • Ages eligible for study: 18 years and older
  • Genders eligible for study: Female
  • Principal Investigator: Dr. Gross
  • Other Physicians who can consent: Dr. Bane, Dr. Cheruvu, Dr. Ditzel, Dr. Guy, Dr. Jilani, Dr. Kathula, Dr. Koduri, Dr. Marinella, Dr. Miller, Dr. Okoye, Dr. Rajsheker, Dr. Romer, Dr. Sabagh, Dr. Setzkorn, Dr. Sheth, Dr. Steinmetz

Study Contact Information